2531 Results (Page 99 of 102)
Healthcare Services Markets Research Reports
Indonesia Biobanks Market Analysis
The Indonesia Biobanks Market was valued at $460.44 Mn in 2023 and is predicted to grow at a CAGR of 8.80% from 2023 to 2030, to $830.95 Mn by 2030. The key drivers of this industry include growing healthcare needs, the national genome project, and the private sector. The industry is primarily dominated by players such as Thermo Fisher Scientific, Merck KGaA, QIAGEN, and Tecan Group among others.
Japan Radiology Service Market Analysis
The Japan Radiology Service Market was valued at $248.6 Mn in 2023 and is predicted to grow at a CAGR of 15.2% from 2023 to 2030, to $669.5 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, aging population, and technological advancements. The prominent players of the Japan Radiology Service Market are Tokyo Medical University Hospital, Keio University Hospital, Osaka University Hospital, Kyoto University Hospital, and National Cancer Center Hospital, among others
Japan Biobanks Market Analysis
The Japan Biobanks Market was valued at $4,770.05 Mn in 2023 and is predicted to grow at a CAGR of 9.30% from 2023 to 2030, to $8,889.24 Mn by 2030. The key drivers of this industry include government support, increasing demand for biomedical research, and a high prevalence of diseases. The industry is primarily dominated by players such as Thermo Fisher Scientific, Merck KGaA, QIAGEN, and Tecan Group among others.
Malaysia Radiology Service Market Analysis
The Malaysia Radiology Service Market was valued at $6.4 Mn in 2023 and is predicted to grow at a CAGR of 14.9% from 2023 to 2030, to $17 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, aging population, and technological advancements. The prominent players of the Malaysia Radiology Service Market are KPJ Damansara Specialty Hospital, Mahkota Medical Centre, Gleneagles Intan Medical Centre, Sunway Medical Centre, and Gleneagles Medical Centre Penang, among others.
Philippines Radiology Service Market Analysis
The Philippines Radiology Service Market was valued at $8.8 Mn in 2023 and is predicted to grow at a CAGR of 15.2% from 2023 to 2030, to $23.7 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, aging population, and growing awareness on early diagnosis. The prominent players of the Philippines Radiology Service Market are Philippine General Hospital, St. Luke's Medical Centre, Makati Medical Centre, Asian Hospital and Medical Centre, The Medical City, and Cardinal Santos Medical Centre, among others.
Malaysia Biobanks Market Analysis
The Malaysia Biobanks Market was valued at $123.38 Mn in 2023 and is predicted to grow at a CAGR of 9% from 2023 to 2030, to $225.54 Mn by 2030. The key drivers of this industry include disease burden, technological advancements, and national genome projects. The industry is primarily dominated by players such as Thermo Fisher Scientific, Merck KGaA, QIAGEN, and Tecan Group among others.
Singapore Radiology Service Market Analysis
The Singapore Radiology Service Market was valued at $4.8 Mn in 2023 and is predicted to grow at a CAGR of 15.3% from 2023 to 2030, to $13 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, aging population, and technological advancements. The prominent players of the Singapore Radiology Service Market are Mount Elizabeth Hospital, National University Hospital (NUH)-Singapore, Gleneagles Hospital, Mount Elizabeth Novena Hospital, Parkway East Hospital, Mount Alvernia Hospital, among others.
Vietnam Biobanks Market Analysis
The Vietnam Biobanks Market was valued at $383.70 Mn in 2023 and is predicted to grow at a CAGR of 9.03% from 2023 to 2030, to $702.77 Mn by 2030. The key drivers of this industry include a focus on precision medicine and genetic testing, increasing disease burden, and national genome projects. The industry is primarily dominated by players such as Thermo Fisher Scientific, Merck KGaA, QIAGEN, and Tecan Group among others.
Vietnam Radiology Service Market Analysis
The Vietnam Radiology Service Market was valued at $20 Mn in 2023 and is predicted to grow at a CAGR of 14.93% from 2023 to 2030, to $53 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, aging population, and healthcare infrastructure development. The prominent players of the Vietnam Radiology Service Market are Vinmec International General Hospital, Cuc International General Hospital, Saint Paul Hospital, Hue Central Hospital (HCH), Hoan My Da Nang Hospital, and Franco-Vietnamese (FV) Hospital, among others.
India Biobanks Market Analysis
The India Biobanks Market was valued at $1,395.59 Mn in 2023 and is predicted to grow at a CAGR of 11.80% from 2023 to 2030, to $3,046.85 Mn by 2030. The key drivers of this industry include government support, the rising prevalence of chronic disease, and advancements in personalized medicine. The industry is primarily dominated by players such as Thermo Fisher Scientific, Merck KGaA, QIAGEN, and Hamilton Company among others.
Egypt Radiology Service Market Analysis
The Egypt Radiology Service Market was valued at $11.2 Mn in 2023 and is predicted to grow at a CAGR of 16.2% from 2023 to 2030, to $32 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, aging population, and growing awareness. The prominent players of the Egypt Radiology Service Market are Andalusia Al Maadi Hospital, Dar Al Fouad Hospital, As-Salam International Hospital, Andalusia Al Shalalat Hospital, and Arab Contractors Medical Center (ACMC), among others.
Philippines Biobanks Market Analysis
The Philippines Biobanks Market was valued at $168.83 Mn in 2023 and is predicted to grow at a CAGR of 9.30% from 2023 to 2030, to $314.62 Mn by 2030. The key drivers of this industry include rising health challenges, growing demand for precision medicine, and technological advancements. The industry is primarily dominated by players such as Merck KGaA, Thermo Fisher Scientific, QIAGEN, and Avantor among others.
Kenya Radiology Service Market Analysis
The Kenya Radiology Service Market was valued at $2.8 Mn in 2023 and is predicted to grow at a CAGR of 15.8% from 2023 to 2030, to $7.8 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, aging population, and growing awareness. The prominent players of the Kenya Radiology Service Market are Aga Khan University Hospital, Nairobi Hospital, Kenyatta National Hospital, Mater Misericordiae Hospital, and M.P. Shah Hospital, among others.
Mexico Biobanks Market Analysis
The Mexico Biobanks Market was valued at $1,151.10 Mn in 2023 and is predicted to grow at a CAGR of 9.05% from 2023 to 2030, to $2,111.02 Mn by 2030. The key drivers of this industry include the prevalence of diseases, advancements in genomic research, and government and institutional support. The industry is primarily dominated by players such as Merck KGaA, Thermo Fisher Scientific, QIAGEN, and Avantor among others.
South Africa Radiology Service Market Analysis
The South Africa Radiology Service Market was valued at $26 Mn in 2023 and is predicted to grow at a CAGR of 15.93% from 2023 to 2030, to $73.2 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, aging population, and growing awareness. The prominent players of the South Africa Radiology Service Market are Midlands Medical Centre (MMC) Private Hospital, Chris Hani Baragwanath Hospital, Cormed Hospital, Life Rosepark Hospital, Mediclinic Hoogland Hospital, and Busamed Lowveld Private Hospital, among others.
Kenya Biobanks Market Analysis
The Kenya Biobanks Market was valued at $53.72 Mn in 2023 and is predicted to grow at a CAGR of 9.90% from 2023 to 2030, to $104.02 Mn by 2030. The key drivers of this industry include disease burden, increasing biomedical research activities, and the growth of personalized medicine. The industry is primarily dominated by players such as Merck KGaA, QIAGEN, Tecan Group, and Becton, Dickinson and Company among others.
India Radiology Service Market Analysis
The India Radiology Service Market was valued at $72.7 Mn in 2023 and is predicted to grow at a CAGR of 17.7% from 2023 to 2030, to $277.6 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, aging population, and technological advancements. The prominent players of the India Radiology Service Market are Gleneagles Global Hospital, BLK Super Specialty Hospital, Apollo Hospitals, Tata Memorial Hospital, and Fortis Hospital, among others.
Canada Genomic Diagnostics Market Analysis
Canada Genomic Diagnostics Market was valued at $2,612 Mn in 2023 and is predicted to grow at a CAGR of 16.5% from 2023 to 2030, to $7,607.72 Mn by 2030. The key drivers of this industry include early disease detection, personalized medicine, and government funding. The industry is primarily dominated by Illumina, 23andMe, Myriad Genetics, and Amgen among others.
US Genomic Diagnostics Market Analysis
US Genomic Diagnostics Market was valued at $13,713 Mn in 2023 and is predicted to grow at a CAGR of 14.5% from 2023 to 2030, to $35,381.06 Mn by 2030. The key drivers of this industry include strong demand for early & preventive care, precision medicine & personalized treatments, and government funding & initiatives. The industry is primarily dominated by Illumina, 23andMe, Myriad Genetics, and Amgen among others.
Saudi Arabia Genomic Diagnostics Market Analysis
Saudi Arabia Genomic Diagnostics Market was valued at $555.05 Mn in 2023 and is predicted to grow at a CAGR of 18% from 2023 to 2030, to $1,768.10 Mn by 2030. The key drivers of this industry include increasing prevalence, government initiatives, and personalized medicine. The industry is primarily dominated by Illumina, 23andMe, Myriad Genetics, and Amgen among others.
UAE Genomic Diagnostics Market Analysis
UAE Genomic Diagnostics Market was valued at $163.25 Mn in 2023 and is predicted to grow at a CAGR of 17.5% from 2023 to 2030, to $504.80 Mn by 2030. The key drivers of this industry include rising prevalence of genetic conditions, growing awareness, and technological advancements. The industry is primarily dominated by Illumina, 23andMe, Myriad Genetics, and Amgen among others.
Brazil Genomic Diagnostics Market Analysis
Brazil Genomic Diagnostics Market was valued at $816.25 Mn in 2023 and is predicted to grow at a CAGR of 17.5% from 2023 to 2030, to $2,523.99 Mn by 2030. The key drivers of this industry include the high burden of chronic diseases, technological advancements, and personalized medicine. The industry is primarily dominated by Illumina, 23andMe, Myriad Genetics, and Amgen among others.
Mexico Genomic Diagnostics Market Analysis
Mexico Genomic Diagnostics Market was valued at $489.75 Mn in 2023 and is predicted to grow at a CAGR of 16.75% from 2023 to 2030, to $1,448.01 Mn by 2030. The key drivers of this industry include increasing demand for personalized medicine, government initiatives, and technological advancements. The industry is primarily dominated by Illumina, 23andMe, Myriad Genetics, and Amgen among others.
Spain Genomic Diagnostics Market Analysis
Spain Genomic Diagnostics Market was valued at $630.15 Mn in 2023 and is predicted to grow at a CAGR of 15.5% from 2023 to 2030, to $1,727.88 Mn by 2030. The key drivers of this industry include technological advancements, personalized medicine, and government initiatives and funding. The industry is primarily dominated by Illumina, 23andMe, Myriad Genetics, and Amgen among others.
UK Genomic Diagnostics Market Analysis
UK Genomic Diagnostics Market was valued at $848.90 Mn in 2023 and is predicted to grow at a CAGR of 14.5% from 2023 to 2030, to $2,190.26 Mn by 2030. The key drivers of this industry include rising disease incidence, increased government support, and growing public awareness. The industry is primarily dominated by Illumina, 23andMe, Myriad Genetics, and Amgen among others.
